![Sapan Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sapan Shah currently works at Glyscend, Inc., as Chief Executive Officer & Director from 2023.
Dr. Shah also formerly worked at Rycarma Therapeutics, Inc., as Chief Executive Officer, Shionogi, Inc., as Chief Executive Officer, and StrideBio, Inc., as Chief Executive Officer.
Dr. Shah received his undergraduate degree from Northwestern University and doctorate degree from Yale University.
| Sociétés | Poste | Début |
|---|---|---|
Glyscend, Inc.
 Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Develops oral metabolic therapeutics for the treatment of type 2 diabetes | Directeur Général | 05/09/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Directeur Général | - |
Rycarma Therapeutics, Inc.
 Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | Directeur Général | - |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 6 |
|---|---|
Rycarma Therapeutics, Inc.
Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
Glyscend, Inc.
Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Develops oral metabolic therapeutics for the treatment of type 2 diabetes | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
